Validity and measurement equivalence of EQ-5D-5L questionnaire among heart failure patients in Malaysia: a cohort study

References

• Lam CSP. Heart failure in Southeast Asia: facts and numbers. ESC Heart Fail. 2015;2(2):46–49. doi: 10.1002/ehf2.12036.
   PubMedGoogle Scholar
• MOH. Clinical practice guidelines: management of heart failure 2019. 4th ed. Malaysia: Ministry of Health; 2019.
   Google Scholar
• Mohamed NF, Yaacob NA, Abdul Rahim AA, et al. Critical factors in quality of life: a qualitative explorations into the experiences of Malaysian with heart failure. Malays J Med Health Sci. 2020;16(2):52–62.
   Google Scholar
• Sullivan PW, Ghushchyan V. Preference-based EQ-5D index scores for chronic conditions in the United States. Med Decis Making. 2006;26(4):410–420. doi: 10.1177/0272989X06290495.
   PubMed Web of Science ®Google Scholar
• Luan L, Hu H, Oldridge N, et al. Psychometric evaluation of the mandarin HeartQoL health-related quality of life questionnaire among patients with ischemic heart disease in China. Value Health Reg Issues. 2022 2022;31:53–60. doi: 10.1016/j.vhri.2022.03.001.
   PubMedGoogle Scholar
• Spiraki C, Kaitelidou D, Papakonstantinou V, et al. Health-related quality of life measurement in patients admitted with coronary heart disease and heart failure to a cardiology department of a secondary urban hospital in Greece. Hellenic J Cardiol. 2008;49(4):241–247.
   PubMed Web of Science ®Google Scholar
• Dunbar SB, Tan X, Lautsch D, et al. Patient-centered outcomes in HFrEF following a worsening heart failure event: a survey analysis. J Card Fail. 2021;27(8):877–887. doi: 10.1016/j.cardfail.2021.05.017.
   PubMed Web of Science ®Google Scholar
• McDonagh TA, Metra M, Adamo M, et al. 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: developed by the task force for the diagnosis and treatment of acute and chronic heart failure of the European society of cardiology (ESC) with the special contribution of the heart failure association (HFA) of the ESC. Eur Heart J. 2021;42(36):3599–3726. doi: 10.1093/eurheartj/ehab368.
   PubMed Web of Science ®Google Scholar
• Heidenreich PA, Bozkurt B, Aguilar D, et al. AHA/ACC/HFSA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2022;145(18):e895–e1032.
   PubMed Web of Science ®Google Scholar
• Feng Y, Kohlmann T, Janssen M, et al. Psychometric properties of the EQ-5D-5L: a systematic review of the literature. Qual Life Res. 2021;30(3):647–673. doi: 10.1007/s11136-020-02688-y.
   PubMed Web of Science ®Google Scholar
• National Institute for Health and Care Excellence N. NICE health technology evaluations: the manual. UK: NICE; 2022.
   Google Scholar
• Daccache C, Karam R, Rizk R, et al. Economic evaluation guidelines in low- and middle-income countries: a systematic review. Int J Technol Assess Health Care. 2022;38(1):e35. doi: 10.1017/S0266462322000186.
   PubMed Web of Science ®Google Scholar
• MOH. Pharmacoeconomic guidelines for Malaysia. Malaysia: Ministry of Health; 2019.
   Google Scholar
• Chilbert MR, Rogers KC, Ciriello DN, et al. Inpatient initiation of Sacubitril/Valsartan. Ann Pharmacother. 2021;55(4):480–495. doi: 10.1177/1060028020947446.
   PubMed Web of Science ®Google Scholar
• Gandhi M, Thumboo J, Luo N, et al. Do chronic disease patients value generic health states differently from individuals with no chronic disease? A case of a multicultural Asian population. Health Qual Life Outcomes. 2015;13(1):8. doi: 10.1186/s12955-014-0200-6.
   PubMedGoogle Scholar
• Pickard AS, Tawk R, Shaw JW. The effect of chronic conditions on stated preferences for health. Eur J Health Econ. 2013;14(4):697–702. doi: 10.1007/s10198-012-0421-8.
   PubMed Web of Science ®Google Scholar
• Wang Y, Tan N-C, Tay E-G, et al. Cross-cultural measurement equivalence of the 5-level EQ-5D (EQ-5D-5L) in patients with type 2 diabetes mellitus in Singapore. Health Qual Life Outcomes. 2015;13(1):103. doi: 10.1186/s12955-015-0297-2.
   PubMedGoogle Scholar
• Lin DY, Cheok TS, Samson AJ, et al. A longitudinal validation of the EQ-5D-5L and EQ-VAS stand-alone component utilising the oxford hip score in the Australian hip arthroplasty population. J Patient Rep Outcomes. 2022;6(1):71. doi: 10.1186/s41687-022-00482-7.
   PubMedGoogle Scholar
• Boczor S, Daubmann A, Eisele M, et al. Quality of life assessment in patients with heart failure: validity of the German version of the generic EQ-5D-5L™. BMC Public Health. 2019;19(1):1464. doi: 10.1186/s12889-019-7623-2.
   PubMed Web of Science ®Google Scholar
• Shafie AA, Vasan Thakumar A, Lim CJ, et al. Psychometric performance assessment of Malay and Malaysian English version of EQ-5D-5L in the Malaysian population. Qual Life Res. 2019;28(1):153–162. doi: 10.1007/s11136-018-2027-9.
   Web of Science ®Google Scholar
• Shafie AA, Chhabra IK, Wong HYJ, et al. Validity of the Malay EQ-5D-3L in the Malaysian transfusion-dependent Thalassemia population. Value Health Reg Issues. 2021;24:47–56. doi: 10.1016/j.vhri.2020.08.003.
   PubMedGoogle Scholar
• Faridah A, Jamaiyah H, Goh A, et al. The validation of the EQ-5D in Malaysian dialysis patients. Med J of Malays. 2010;65(Suppl A):114–119.
   PubMedGoogle Scholar
• Rankin J, Rowen D, Howe A, et al. Valuing health-related quality of life in heart failure: a systematic review of methods to derive quality-adjusted life years (QALYs) in trial-based cost–utility analyses [ReviewPaper. Heart Fail Rev. 2019;24(4):549–563. doi: 10.1007/s10741-019-09780-7.
   PubMed Web of Science ®Google Scholar
• Di Tanna G, Urbich M, WIrtz H, et al. Health state utilities of patients with heart failure: a systematic literature review. Pharmacoeconomics. 2021;39(2):211–229. doi: 10.1007/s40273-020-00984-6.
   PubMed Web of Science ®Google Scholar
• Kuan WC, Sim R, Wong WJ, et al. Economic evaluations of guideline-directed medical therapies for heart failure with reduced ejection fraction: a systematic review. Value Health. 2023;S1098-3015(23):02613–0261X.
   Google Scholar
• Di Tanna GL, Chen S, Bychenkova A, et al. Economic evaluations of pharmacological treatments in heart failure patients: a methodological review with a focus on key model drivers. Pharmacoecon Open. 2020;4(3):397–401. doi: 10.1007/s41669-019-00173-y.
   PubMed Web of Science ®Google Scholar
• Varatharajan S, Chen W-S. Reliability and validity of EQ-5D in Malaysian population. Appl Res Qual Life. 2011;7(2):209–221. doi: 10.1007/s11482-011-9156-4.
   Web of Science ®Google Scholar
• Shafie AA, Hassali MA, Liau SY. A cross-sectional validation study of EQ-5D among the Malaysian adult population. Qual Life Res. 2011;20(4):593–600. doi: 10.1007/s11136-010-9774-6.
   PubMed Web of Science ®Google Scholar
• von Elm E, Altman DG, Egger M, et al. Strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. BMJ. 2007 2007;335(7624):806–808. doi: 10.1136/bmj.39335.541782.AD.
   PubMed Web of Science ®Google Scholar
• Mokkink LB, Terwee CB, Patrick DL, et al. The COSMIN checklist for assessing the methodological quality of studies on measurement properties of health status measurement instruments: an international Delphi study. Qual Life Res. 2010;19(4):539–549. doi: 10.1007/s11136-010-9606-8.
   PubMed Web of Science ®Google Scholar
• Krishnan M, Sharmini S. English language use of the Malaysian Tamil diaspora. J Multiling Multicult Dev. 2022. doi: 10.1080/01434632.2021.2020800.
   PubMed Web of Science ®Google Scholar
• Swinburn P, Shingler S, Ong S, et al. Assessing the health-related quality of life in patients hospitalised for acute heart failure. Bri J Cardiol. 2013;20(72):6.
   Google Scholar
• García-Soleto A, Parraza-Diez N, Aizpuru-Barandiaran F, et al. Comparative study of quality of life after hospital-at-home or in-patient admission for acute decompensation of chronic heart failure. WJCD. 2013;03(01):174–181. doi: 10.4236/wjcd.2013.31A025.
   Google Scholar
• Rutherford C, Costa D, Mercieca-Bebber R, et al. Mode of administration does not cause bias in patient-reported outcome results: a meta-analysis. Qual Life Res. 2016;25(3):559–574. doi: 10.1007/s11136-015-1110-8.
   PubMed Web of Science ®Google Scholar
• Gandhi M, Tan RS, Lim SL, et al. Investigating 5-Level EQ-5D (EQ-5D-5L) values based on preferences of patients with heart disease. Value Health. 2022;25(3):451–460. doi: 10.1016/j.jval.2021.09.010.
   PubMed Web of Science ®Google Scholar
• Shafie AA, Vasan Thakumar A, Lim CJ, et al. EQ-5D-5L valuation for the malaysian population. Pharmacoeconomics. 2019;37(5):715–725. doi: 10.1007/s40273-018-0758-7.
   PubMed Web of Science ®Google Scholar
• Liu Y, Millsap RE, West SG, et al. Testing measurement invariance in longitudinal data with ordered-categorical measures. Psychol Methods. 2017;22(3):486–506. doi: 10.1037/met0000075.
   PubMed Web of Science ®Google Scholar
• Cheung GW, Cooper-Thomas HD, Lau RS, et al. Reporting reliability, convergent and discriminant validity with structural equation modeling: a review and best-practice recommendations. Asia Pac J Manag. 2023;1–39. doi: 10.1007/s10490-023-09871-y.
   Web of Science ®Google Scholar
• Xia Y, Yang Y. CFI, and TLI in structural equation modeling with ordered categorical data: the story they tell depends on the estimation methods. Behav Res Methods. 2018;51(1):409–428. doi: 10.3758/s13428-018-1055-2.
   Web of Science ®Google Scholar
• Berg J, Lindgren P, Mejhert M, et al. Determinants of utility based on the EuroQol five-dimensional questionnaire in patients with chronic heart failure and their change over time: results from the Swedish heart failure registry. Value Health. 2015;18(4):439–448. doi: 10.1016/j.jval.2015.02.003.
   PubMed Web of Science ®Google Scholar
• Sepehrvand NS, Spertus JA, Dyck JRB, et al. Change of health-related quality of life over time and its association with patient outcomes in patients with heart failure. J Am Heart Assoc. 2020;9(17):e017278. doi: 10.1161/JAHA.120.017278.
   PubMed Web of Science ®Google Scholar
• Göhler A, Geisler BP, Manne JM, et al. Utility estimates for decision–analytic modeling in chronic heart failure—health states based on New York Heart Association classes and number of rehospitalizations. Value Health. 2009;12(1):185–187. doi: 10.1111/j.1524-4733.2008.00425.x.
   PubMed Web of Science ®Google Scholar
• Zheng Y, Dou L, Fu Q, et al. Responsiveness and minimal clinically important difference of EQ-5D-5L in patients with coronary heart disease after percutaneous coronary intervention: a longitudinal study. Front Cardiovasc Med. 2023;10:1074969. doi: 10.3389/fcvm.2023.1074969.
   PubMed Web of Science ®Google Scholar
• Koh D, Abdullah AMK, Wang P, et al. Validation of Brunei’s Malay EQ-5D questionnaire in patients with type 2 diabetes. PLOS ONE. 2016;11(11):e0165555. doi: 10.1371/journal.pone.0165555.
   PubMed Web of Science ®Google Scholar
• Senn SS. Statistical issues in drug development. Chichester: John Wiley & Sons, Incorporated; 1997.
   Google Scholar
• Luo N, Chew LH, Fong KY, et al. Do English and Chinese EQ-5D versions demonstrate measurement equivalence? An exploratory study. Health Qual Life Outcomes. 2003;1(1):7. doi: 10.1186/1477-7525-1-7.
   PubMedGoogle Scholar
• Lee CF, Ng R, Luo N, et al. The English and Chinese versions of the five-level EuroQoL group’s five-dimension questionnaire (EQ-5D) were valid and reliable and provided comparable scores in Asian breast cancer patients. Support Care Cancer. 2012;21(1):201–209. doi: 10.1007/s00520-012-1512-x.
   PubMed Web of Science ®Google Scholar
• Cheung Y-B, Thumboo J, Goh C, et al. The equivalence and difference between the English and Chinese versions of two major, cancer-specific, health-related quality-of-life questionnaires. Cancer. 2004;101(12):2874–2880. doi: 10.1002/cncr.20681.
   PubMed Web of Science ®Google Scholar
• Albuquerque de Almeida F, Al MJ, Koymans R, et al. Impact of hospitalisation on health-related quality of life in patients with chronic heart failure. Health Qual Life Outcomes. 2020;18(1):262. doi: 10.1186/s12955-020-01508-8.
   PubMedGoogle Scholar
• Parizo JT, Goldhaber-Fiebert JD, Salomon JA, et al. Cost-effectiveness of dapagliflozin for treatment of patients with heart failure with reduced ejection fraction. JAMA Cardiol. 2021;6(8):926–935. doi: 10.1001/jamacardio.2021.1437.
   PubMed Web of Science ®Google Scholar
• Stein G, Teng T-HK, Tay WT, et al. Ethnic differences in quality of life and its association with survival in patients with heart failure. Clin Cardiol. 2020;43(9):976–985. doi: 10.1002/clc.23394.
   PubMed Web of Science ®Google Scholar
• Griffiths A, Paracha N, Davies A, et al. The cost effectiveness of ivabradine in the treatment of chronic heart failure from the UK National Health Service perspective. Heart. 2014;100(13):1031–1036. doi: 10.1136/heartjnl-2013-304598.
   PubMed Web of Science ®Google Scholar